Company Filing History:
Years Active: 2025
Title: Marin Scalbert: Innovator in Biological Sample Analysis
Introduction
Marin Scalbert is a notable inventor based in Paris, France. He has made significant contributions to the field of biological sample analysis, particularly through his innovative patent. His work focuses on improving the classification and counting of objects in biological samples, which has important implications for medical diagnostics.
Latest Patents
Marin Scalbert holds a patent for a method titled "Systematic characterization of objects in a biological sample." This method is designed for classifying and counting objects recoverable from a urine sample processed onto a slide. The process involves several steps, including receiving digitalized images of the slide, detecting connected components through image segmentation, and classifying these components into countable and uncountable categories. For countable components, an object detection model is utilized to determine the number of objects in each class, while a semantic segmentation model is employed for uncountable components. The final output provides a comprehensive count of objects for each class, enhancing the accuracy of biological sample analysis.
Career Highlights
Marin Scalbert is currently associated with Vitadx International, where he applies his expertise in biological sample analysis. His innovative approach has positioned him as a key figure in the development of advanced diagnostic methods. His work not only contributes to the scientific community but also has practical applications in healthcare.
Collaborations
Marin collaborates with talented professionals such as Thibaut Troude and Florent Couzinie-Devy. These collaborations foster a dynamic environment for innovation and research, allowing for the exchange of ideas and expertise.
Conclusion
Marin Scalbert's contributions to the field of biological sample analysis through his patent demonstrate his commitment to advancing medical diagnostics. His innovative methods have the potential to significantly impact healthcare practices.